CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castle, P. E.
Right arrow Articles by Lorincz, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castle, P. E.
Right arrow Articles by Lorincz, A. T.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 1311-1314, May 2005
© 2005 American Association for Cancer Research


Short Communication

Semiquantitative Human Papillomavirus Type 16 Viral Load and the Prospective Risk of Cervical Precancer and Cancer

Philip E. Castle1, Mark Schiffman1, David R. Scott2, Mark E. Sherman1, Andrew G. Glass2, Brenda B. Rush2, John E. Schussler3, Sholom Wacholder1 and Attila T. Lorincz4

1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, NIH, Bethesda, Maryland; 2 Kaiser Permanente, Portland, Oregon; 3 Information Management Services, Silver Spring, Maryland; and 4 Digene, Gaithersburg, Maryland

Requests for reprints: Attila T. Lorincz, Digene Corporation, 1201 Clopper Road, Gaithersburg, MD 20878. E-mail: attila.lorincz{at}digene.com

We examined whether higher human papillomavirus type 16 (HPV16) viral load predicted risk of cervical intraepithelial neoplasia 3 (CIN3) or cancer (together termed ≥CIN3) within a cohort of 20,810 women followed for 10 years with cytologic screening. Semiquantitative viral load for HPV16 was measured on baseline cervicovaginal specimens using a type-specific hybridization probe test with signal amplification. An increased risk of ≥CIN3 associated with higher HPV16 viral load was found only among cytologically negative women in early follow-up, suggesting that these cases were related to the detection of prevalent lesions missed at baseline. Women with higher HPV16 viral load were more likely to undergo ablative treatment during follow-up than those with lower viral load (Ptrend = 0.008), possibly diminishing any additional risk for ≥CIN3 attributable to higher HPV16 viral loads.




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
J. L. K. Cheung, T. H. Cheung, J. W. T. Tang, and P. K. S. Chan
Increase of Integration Events and Infection Loads of Human Papillomavirus Type 52 with Lesion Severity from Low-Grade Cervical Lesion to Invasive Cancer
J. Clin. Microbiol., April 1, 2008; 46(4): 1356 - 1362.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. B. Kovacic, P. E. Castle, R. Herrero, M. Schiffman, M. E. Sherman, S. Wacholder, A. C. Rodriguez, M. L. Hutchinson, M. C. Bratti, A. Hildesheim, et al.
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.
Cancer Res., October 15, 2006; 66(20): 10112 - 10119.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.